Earnings · China A-shares
Guiyang Xintian Pharmaceutical Co. Ltd. Class A (002873) earnings
Guiyang Xintian Pharmaceutical Co. Ltd. Class A published its Q3 report on 2026-10-28: net profit +3.24% year on year, -12.15% excluding one-off items. Wave Radar's earnings-quality score is 90 of 100 (Sound). The stock moved -1.85% in the 3 trading days after the report.
- Report
- Q3 report
- Published
- 2026-10-28
- Period end
- 2026-09-30
- Net profit YoY
- +3.24%
- Excl. one-offs YoY
- -12.15%
- Net profit QoQ
- +766.91%
- Result
- Neutral
- Quality score
- 90
- Quality
- Sound
Stock move after the report
Trading days from the first tradeable session; dividend-adjusted. "vs index" is the excess return over CSI 300 for A-shares.
| After | Return | vs index |
|---|---|---|
| 1 day | -0.79% | — |
| 3 days | -1.85% | — |
| 7 days | -0.40% | — |
| 14 days | -3.96% | — |
Report history
Over the last 8 reports, net profit grew year on year in 1 of them. The stock rose in the 3 trading days after 4 of 7 reports (average +2.23%).
| Report | Published | Net profit | Profit YoY | Excl. one-offs YoY | Revenue YoY | EPS | ROE | 3 days after | 30 days after | 30d vs index |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026 Q3 report | 2026-10-29 | ¥16.71M | +3.24% | -12.15% | -9.87% | 0.07 | 1.31% | -1.85% | — | — |
| 2026 interim report | 2026-08-26 | ¥4.86M | -15.69% | +11.31% | -7.39% | 0.02 | 0.39% | -0.80% | -6.26% | +0.73% |
| 2026 Q1 report | 2026-04-30 | ¥3.50M | -16.53% | +8.84% | -7.53% | 0.01 | 0.28% | +1.32% | -18.53% | -20.58% |
| 2025 annual report | 2026-03-31 | ¥9.11M | -82.59% | -84.81% | -12.57% | 0.04 | 0.75% | +2.76% | -4.33% | -12.75% |
| 2025 Q3 report | 2025-10-31 | ¥16.18M | -73.47% | -67.93% | -15.47% | 0.07 | 1.35% | +4.29% | -4.29% | +0.40% |
| 2025 interim report | 2025-07-31 | ¥5.77M | -80.99% | -87.87% | -18.88% | 0.02 | 0.48% | +11.92% | +4.19% | -3.01% |
| 2025 Q1 report | 2025-04-25 | ¥4.19M | -73.11% | -81.21% | +8.93% | 0.02 | 0.35% | -2.05% | +14.66% | +11.41% |
| 2024 annual report | 2025-04-25 | ¥52.32M | -35.30% | -53.16% | -10.11% | 0.24 | 5.02% | -2.05% | +14.66% | +11.41% |
The last 8 reports. Net profit is attributable to shareholders and year-to-date (a Q3 report covers the first nine months). Moves count trading days from the first tradeable session after publication; "30d vs index" is the excess return over CSI 300.
How to read this
Results are grouped by reported profit growth (great, good, neutral, bad or a loss). For China A-shares the quality score starts at 100 and loses points for gaps a reader can check: operating cash falling short of profit, receivables or inventory outrunning revenue, profit that rests on one-off items or subsidies, heavy goodwill and a qualified audit opinion.
Figures are generated automatically from Wave Radar's published market data and refresh after each market close.